Suppr超能文献

[肝素/双氢麦角胺与肝素/新抗凝剂在股骨转子间骨折髓内钉固定术中预防血栓形成的比较]

[Thrombosis prevention with heparin/dihydroergotamine versus heparin/Sintrom in Ender nailing of pertrochanteric fractures].

作者信息

Schlag G, Gaudernak T, Pelinka H, Redl H, Kuderna H, Poigenfürst J

机构信息

Ludwig-Boltzmann-Institut für Experimentelle Traumatologie, Wien.

出版信息

Unfallchirurgie. 1988 Feb;14(1):12-21.

PMID:3284133
Abstract

The effect of either (randomized) Heparin/Dihydroergotamine (HDHE) or heparin-acenocoumarin (Hep/S) on the incidence of deep-vein thrombosis in the legs was studied in 212 women of more than 60 years of age with hip fractures. All patients were screened with the 125-I-fibrinogen uptake test (FUT) confirmed by a bilateral ascending venogram upon positive FUT. This revealed good sensitivity and specificity (85/84%) for the FUT. Deep vein thrombosis developed in 37.6% of the HDHE group and in 59.1% of the Hep/S group which was significantly different (p less than 0.005). The calculated thrombosis risk was significantly diminished (by 38% - p less than 0.005) in the HDHE group. Therefore we conclude that in traumatology Heparin/Dihydroergotamine seems to be the prophylaxis of choice.

摘要

对212名60岁以上髋部骨折的女性患者,研究了(随机分组的)肝素/双氢麦角胺(HDHE)或肝素/醋硝香豆素(Hep/S)对下肢深静脉血栓形成发生率的影响。所有患者均采用125-I-纤维蛋白原摄取试验(FUT)进行筛查,FUT结果阳性时通过双侧上行静脉造影加以确认。这显示FUT具有良好的敏感性和特异性(85/84%)。HDHE组深静脉血栓形成发生率为37.6%,Hep/S组为59.1%,二者差异显著(p<0.005)。HDHE组计算得出的血栓形成风险显著降低(降低38%,p<0.005)。因此我们得出结论,在创伤学领域,肝素/双氢麦角胺似乎是首选的预防药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验